2-[18F]-fluoro-2-desoxy-D-glucose positron emission tomography initial staging impacts on survival in Hodgkin lymphoma

AIM:To assess the prognostic value and risk classification improvement of metabolic staging(MS)with Initial2-[18F]-fluoro-2-desoxy-D-glucose positron emission tomography(FDG-PET)in initial staging of Hodgkin’s Lymphoma(HL)patients to predict 5 years overall survival(5y-OS)and event free survival(EFS...

Full description

Saved in:
Bibliographic Details
Published in:World journal of radiology Vol. 5; no. 12; pp. 484 - 490
Main Authors: Cerci, Juliano J, Linardi, Camila C G, Pracchia, Luís F, Junior, José Soares, Trindade, Evelinda, Delbeke, Dominique, Cerci, Rodrigo J, Carr, Robert, Meneghetti, José C, Buccheri, Valeria
Format: Journal Article
Language:English
Published: United States Baishideng Publishing Group Co., Limited 28-12-2013
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:AIM:To assess the prognostic value and risk classification improvement of metabolic staging(MS)with Initial2-[18F]-fluoro-2-desoxy-D-glucose positron emission tomography(FDG-PET)in initial staging of Hodgkin’s Lymphoma(HL)patients to predict 5 years overall survival(5y-OS)and event free survival(EFS).METHODS:A total of 275 patients were included in this retrospective study,155 patients were staged with conventional anatomical staging(AS),and 120 also submitted to MS(FDG-PET).Prognostic analysis compared 5y-OS and 5y-EFS of patients staged with AS and MS.Risk-adjusted models incorporated clinical risk factors,computed tomography and FDG-PET staging.RESULTS:During the follow up of 267 evaluated patients,220(122 AS and 98 MS)achieved complete remission after first-line therapy(median follow-up:70±29 mo),treatment failure occurred in 79 patients and 34 died.The 5y-EFS for early vs advanced disease in AS patients was 79.3%and 66.7%,and 85.6%and53.6%in MS patients,respectively(P<0.01).The5y-OS for early and advanced disease with AS was91.3%and 81.5%,and 97.5%and 80.7%for patients staged with MS,respectively.Cox proportional hazards analysis demonstrated that FDG-PET added signifcant prognostic information and improved risk prediction(P=0.02).CONCLUSION:Initial staging FDG-PET could be used as an accurate and independent predictor of OS and EFS in HL,with impact in 5y-EFS and OS.
Bibliography:Juliano J Cerci;Camila C G Linardi;Luís F Pracchia;José Soares Junior;Evelinda Trindade;Dominique Delbeke;Rodrigo J Cerci;Robert Carr;José C Meneghetti;Valeria Buccheri;Department of Nuclear Medicine, Heart Institute (InCor), University of Sāo Paulo Medical School;Division of PET/CT, Quanta-Diagnóstico Nuclear;Division of Hematology, Clinical Hospital of the University of Sāo Paulo Medical School;Health Technology Assessment/Executive Direction, Heart Institute (InCor), University of Sāo Paulo Medical School;Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center;Department of Haematology, St Thomas’ Hospital
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Supported by The Brazilian Ministry of Health
Telephone: +55-41-33629778 Fax: +55-41-33629778
Author contributions: Cerci JJ, Linardi CCG, Pracchia LF and Buccheri V contributed equally to this work performing research, study design, results analysis and writing the paper; Soares Junior J, Trindade E, Cerci RJ, Carr R, Delbeke D and Meneghetti JC contributed to design, analyze and write the paper.
Correspondence to: Juliano Julio Cerci, MD, PhD, Division of PET/CT, Quanta-Diagnóstico Nuclear, R. Almirante Tamandaré, 1000. Curitiba (PR), 80045-170, Brazil. cercijuliano@hotmail.com
ISSN:1949-8470
1949-8470
DOI:10.4329/wjr.v5.i12.484